4-(N-cyclopentylamidino)-1,2-phenylene diamine | 165596-46-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(N-cyclopentylamidino)-1,2-phenylene diamine
• 英文别名: 3,4-diamino-N'-cyclopentylbenzenecarboximidamide
• CAS: 165596-46-3
• 化学式: C₁₂H₁₈N₄
• 分子量: 218.302
• InChiKey: BYDFGYHQOGWROR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  90.4
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-[2-(4-甲酰基苯基)乙基]苯甲醛 、 4-(N-cyclopentylamidino)-1,2-phenylene diamine 在 对苯醌 作用下， 以 乙醇 为溶剂， 生成 N'-cyclopentyl-2-[4-[2-[4-[6-(N'-cyclopentylcarbamimidoyl)-1H-benzimidazol-2-yl]phenyl]ethyl]phenyl]-3H-benzimidazole-5-carboximidamide
  参考文献：
  名称：

  新型双抗-苯并咪唑类化合物的合成及其体外活性

  摘要：

  已经合成了一类新型的新型双苯并咪唑二am化合物，并对其体外抗菌活性进行了评估，包括耐药菌菌株。最有效的化合物1的抗MRSA和抗VRE活性比万古霉素更具活性。这类化合物的作用机理似乎不同于现有的抗生素。双-苯并咪唑二am化合物作为一类新的有效的抗MRSA和抗VRE剂具有潜力，需要进一步研究。

  DOI：

  10.1016/j.bmcl.2009.01.075
• 作为产物：
  描述：

  4-(N-cyclopentylamidino)-2-nitroaniline 在 palladium on activated charcoal 氢气 作用下， 以 甲醇 为溶剂， 反应 1.0h， 以72%的产率得到4-(N-cyclopentylamidino)-1,2-phenylene diamine
  参考文献：
  名称：

  Extended Aromatic Furan Amidino Derivatives as Anti-Pneumocystis carinii Agents

  摘要：

  The. syntheses of nine new derivatives of 2,5-bis[4-(N-alkylamidino)phenyl]furans with extended aromatic systems are reported. The interaction of these dicationic furans with poly(dA)*poly(dT) and with the duplex oligomers d(CGCGAATTCGCG)(2) and d(GCGAATTCGC)(2) was determined by T(m) measurement, and the effectiveness of these compounds against the immunosuppressed rat model of Pneumocystis carinii was evaluated. At a screening dose of 10 mu mol/kg, 4 of the 12 amidino furans described here are more active than the parent compound 1. In general, extension of the aromatic system in the absence of a substitution of the amidino nitrogens resulted in higher affinity for DNA than the parent compound as judged by the larger Delta T(m) values and suggests enhanced van der Waals interactions in the amidino furan-DNA complex. Three of the compounds, 3, 5, and 11, yield cysts counts of less than 0.1% of control when administered at a dosage of 10 mu mol/kg. Compound 3, which does not have an extended aromatic system, is the most active derivative. Although a direct correlation between anti-P. carinii activity and DNA binding affinity was not observed, all compounds which have significant activity have large Delta T(m) values.

  DOI：

  10.1021/jm980230c

文献信息

• New quinoline-arylamidine hybrids: Synthesis, DNA/RNA binding and antitumor activity
  作者：Luka Krstulović、Ivana Stolić、Marijana Jukić、Teuta Opačak-Bernardi、Kristina Starčević、Miroslav Bajić、Ljubica Glavaš-Obrovac

  DOI：10.1016/j.ejmech.2017.05.054

  日期：2017.9

  (groups I (2a-g) and II (5a-g)) or flexible -NH-CH2-CH2-O- (groups III (8a-g) and IV (10a-g)) linker were synthesized, and their DNA/RNA binding properties and cytotoxic activity were tested, against several human cancer lines. The compounds and their interaction with DNA and RNA were studied by UV–Vis and CD spectroscopy. The obtained results showed that the binding affinity of the investigated compounds

  通过刚性-O-（I组（2a-g）和II（5a-g））或柔性-NH-CH 2 -CH 2 - O-（第三组（8a-g）和第四组（10a-g））合成了连接子，并测试了其对几种人类癌症细胞系的DNA / RNA结合特性和细胞毒性活性。通过UV-Vis和CD光谱研究了这些化合物及其与DNA和RNA的相互作用。获得的结果表明，所研究化合物的结合亲和力随着能够与ds-多核苷酸形成氢键的基团的长度和数目的增加而成比例地增加。通过降低所研究化合物的结构刚度还可以实现结合的改善，新的杂合化合物优先结合ctDNA。对于大部分的DNA / RNA槽是占主导地位的结合位点，除了从基团的化合物II其在polyA-polyU中的插入是主要的结合模式。通过MTT测试对正常（MDCK1），癌（HeLa和CaCo2）和白血病细胞系（Raji和K462）的抗增殖作用进行了测试。所有研究的化合物的GI 50值范围从5到大于100×10
• Synthesis and structure–activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents
  作者：Laixing Hu、Maureen L. Kully、David W. Boykin、Norman Abood

  DOI：10.1016/j.bmcl.2009.06.077

  日期：2009.8

  A series of dicationic diaryl ethers have been synthesized and evaluated for in vitro antibacterial activities, including drug resistant bacterial strains. Most of these compounds have shown potent antibacterial activities. Several compounds, such as piperidinyl and thiomorpholinyl compounds 9e and 9l, improved the antimicrobial selectivity and kept potent anti-MRSA and anti-VRE activity. The most

  已经合成了一系列双阳离子二芳基醚，并对其体外抗菌活性进行了评估，包括耐药菌菌株。这些化合物大多数已显示出有效的抗菌活性。几种化合物，例如哌啶基和硫吗啉基化合物9e和9l提高了抗菌选择性，并保持了有效的抗MRSA和抗VRE活性。最有效的双吲哚二苯醚19的抗MRSA MIC值为⩽0.06μg/ mL，并具有增强的抗菌选择性。
• SUBSTITUTED TETRAHYDROPYRROLOQUINOLINES
  申请人：Enderle Holger

  公开号：US20100120818A1

  公开（公告）日：2010-05-13

  Compounds of the formula (I), in which R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 and m have the meanings indicated in Claim 1 , can be employed, inter alia, for the treatment of tumours.

  化合物的公式（I），其中R1、R2、R3、R4、R5和R6以及m具有权利要求1中指示的含义，可以用于治疗肿瘤。
• SUBSTITUTED TETRAHYDROQUINOLINES
  申请人：Schiemann Kai

  公开号：US20100022579A1

  公开（公告）日：2010-01-28

  Compounds of the formula (I), in which R 1 , R 2 , R 3 , R 4 , R 5 , X, Y, W, Q 1 , Q 2 , Z, s and m have the meanings indicated in claim 1, can be employed, inter alia, for the treatment of tumours.

  化合物的结构式（I）中，其中R1、R2、R3、R4、R5、X、Y、W、Q1、Q2、Z、s和m具有权利要求书中指定的含义，可用于治疗肿瘤。
• TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN
  申请人：Schiemann Kai

  公开号：US20100022530A1

  公开（公告）日：2010-01-28

  Compounds of the formula (I) in which A 1 , A 2 , R 1 , X 1 , X 2 , X 3 , Y, R 2 , Cy and n have meanings indicated in claim 1 , can be employed, inter alia, for the treatment of tumours.

  公式（I）中A1，A2，R1，X1，X2，X3，Y，R2，Cy和n具有权利要求1中所示的含义的化合物，可以用于治疗肿瘤等疾病。